Hearing-loss drugmaker Sound Pharmaceuticals posts strong clinical results, eyes an IPO

Sound Pharmaceuticals CEO Dr. Jonathan Kil. (Sound Photo)

Sound Pharmaceuticals, a Seattle-based drugmaker that is creating a first-of-its-kind treatment for hearing loss, recently reported encouraging top-line results from a Phase II clinical trial and is eyeing a potential IPO next year.

Sound has developed a synthetic drug containing

This post was originally published on this site


Check out http://contacted.org